证券代码：300807 证券简称：天迈科技 公告编号：2024-031 郑州天迈科技股份有限公司 关于召开 2023 年年度股东大会的通知 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 根据郑州天迈科技股份有限公司（以下简称"公司"）第四届董事会第六次 会议决议，公司决定于 2024 年 5 月 17 日召开 2023 年年度股东大会。本次股东 大会采用现场投票与网络投票相结合的方式召开，现将本次会议的有关事项通知 如下： 一、召开会议的基本情况 1、股东大会届次：2023 年年度股东大会。 2、会议召集人：公司董事会。 3、会议召开的合法、合规性 公司第四届董事会第六次会议审议通过了《关于召开 2023 年年度股东大会 的议案》，决定召开 2023 年年度股东大会。本次股东大会的召集程序符合有关 法律、行政法规、部门规章、规范性文件和《公司章程》等的规定。 4、会议召开的日期、时间 （1）现场会议时间：2024 年 5 月 17 日下午 15:00 开始； （2）网络投票时间：2024 年 5 月 17 日。 于 2024 年 5 月 13 日下午收市时在中 ...

证券代码：300807 证券简称：天迈科技 公告编号：2024-022 郑州天迈科技股份有限公司 关于向银行申请综合授信额度的公告 特此公告。 郑州天迈科技股份有限公司 董事会 二〇二四年四月二十六日 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 郑州天迈科技股份有限公司（以下简称"公司"）于 2024 年 4 月 26 日召开 第四届董事会第六次会议，审议通过了《关于 2024 年度向银行申请综合授信额 度的议案》。根据公司经营的总体情况，结合公司资金使用计划的需要，公司拟 向金融机构申请不超过人民币 1 亿元综合授信额度，具体情况如下： | 序号 | 申请授信银行名称 | 拟申请授信额度（万元） | | --- | --- | --- | | 1 | 中信银行股份有限公司郑州分行 | 5000 | | 2 | 中国工商银行河南省分行 | 5000 | | | 合计 | 10,000 | 上述授信包括但不限于短期流动资金贷款、保理、银行承兑汇票、商业承兑 汇票、保函、信用证等形式。具体授信日期、授信期限及利率以各方签署的合同 为准。以上授信额度不等于公司的实 ...

董事会认为 2023 年年度报告真实反映了公司 2023 年度的财务状况和经营 成果，不存在虚假记载、误导性陈述和重大遗漏。 具体内容详见公司披露于巨潮资讯网（http://www.cninfo.com.cn）的《2023 年年度报告》及其摘要。 证券代码： 300807 证券简称：天迈科技 公告编号：2024-013 郑州天迈科技股份有限公司 第四届董事会第六次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 郑州天迈科技股份有限公司（以下简称"公司"）第四届董事会第六次会议于 2024 年 4 月 26 日在郑州市高新区莲花街 316 号 10 号楼公司一楼会议室以现场 方式召开。会议通知已于 2024 年 4 月 16 日通过电子邮件的方式送达各位董事。 本次会议应出席董事 7 人，实际现场出席董事 7 人。 会议由董事长郭建国先生主持，监事、高级管理人员列席。会议召开符合有 关法律、法规、规章和《公司章程》的规定。经各位董事认真审议，会议形成了 如下决议： 二、董事会会议审议情况 （一）审议通过《关于 2023 年度报 ...

根据《上市公司独立董事管理办法》等有关规定，董事会审计委员会委员应 当为不在上市公司担任高级管理人员的董事。根据上述规定，为完善公司治理结 构，充分发挥董事会专门委员会在上市公司治理中的作用，公司于 2024 年 4 月 26 日召开第四董事会第六次会议审议通过了《关于调整审计委员会组成人员的 议案》，对第四届董事会审计委员会部分委员进行调整。 证券代码：300807 证券简称：天迈科技 公告编号：2024-026 本次调整完成后，公司董事会秘书刘洪宇先生不再担任审计委员会委员，由 公司董事翟继东先生担任审计委员会委员，任期自本次董事会审议通过之日起至 本届董事会任期届满之日止。 调整后的公司第四届董事会审计委员会委员为：吴跃平先生（独立董事）、 司爱军先生（独立董事）、翟继东先生，其中吴跃平先生担任主任委员（召集人）。 郑州天迈科技股份有限公司 关于调整审计委员会组成人员的公告 特此公告。 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 二〇二四年四月二十六日 董事会 郑州天迈科技股份有限公司 ...

[Main Financial Data](index=2&type=section&id=Item%20I.%20Main%20Financial%20Data) [Key Accounting Data and Financial Indicators](index=2&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%20Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1 2024, operating revenue declined by **30.83%** year-over-year, net loss attributable to shareholders widened, and net cash flow from operating activities significantly improved Key Financial Indicators for Q1 2024 | Indicator | Current Period | Prior Period | Year-over-Year Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue (CNY) | 13,321,754.87 | 19,259,097.38 | -30.83% | | Net Profit Attributable to Shareholders (CNY) | -20,036,186.01 | -15,735,302.96 | -27.33% | | Net Profit Attributable to Shareholders Excluding Non-recurring Gains/Losses (CNY) | -20,695,553.84 | -16,271,106.38 | -27.19% | | Net Cash Flow from Operating Activities (CNY) | -21,123,867.33 | -41,926,612.16 | 49.62% | | Basic Earnings Per Share (CNY/share) | -0.29 | -0.23 | -26.09% | | Total Assets (CNY) | 681,325,696.81 | 721,936,739.67 | -5.63% (vs. end of prior year) | | Owners' Equity Attributable to Shareholders (CNY) | 524,810,370.20 | 544,831,692.35 | -3.67% (vs. end of prior year) | [Non-recurring Gains and Losses Items and Amounts](index=2&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%20Non-recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) During the current period, total non-recurring gains and losses amounted to **CNY 659,367.83**, primarily from government grants, resulting in a net loss of **CNY 20.70 million** after exclusion Non-recurring Gains and Losses Items for Q1 2024 | Item | Amount for Current Period (CNY) | | :--- | :--- | | Government Grants Recognized in Current Profit/Loss | 1,034,300.00 | | Reversal of Impairment Provisions for Receivables Subject to Separate Impairment Testing | 25,200.00 | | Other Non-operating Income and Expenses Excluding the Above | -294,184.90 | | Less: Income Tax Impact | 105,947.27 | | **Total** | **659,367.83** | [Analysis of Major Financial Data Changes](index=3&type=section&id=%EF%BC%88%E4%B8%89%EF%BC%89%20Analysis%20of%20Major%20Accounting%20Data%20and%20Financial%20Indicators%20Changes%20and%20Reasons) The company explained key financial data changes for the quarter, attributing revenue decline to reduced sales orders, improved operating cash flow to lower procurement payments, and increased fixed asset acquisitions and bank borrowings [Balance Sheet Item Change Analysis](index=3&type=section&id=1%E3%80%81Major%20Balance%20Sheet%20Changes) At period-end, receivables financing and prepayments significantly increased due to business activities, while taxes payable and other payables substantially decreased due to payment settlements Major Balance Sheet Item Changes | Item | Change (%) | Primary Reason for Change | | :--- | :--- | :--- | | Receivables Financing | 41.16% | Increase in Bank Acceptance Bills Received | | Prepayments | 39.59% | Increase in Prepaid Purchase Payments | | Other Current Assets | 71.98% | Increase in Input VAT to be Deducted | | Taxes Payable | -85.10% | Payment of Taxes Accrued at Prior Year-end | | Other Payables | -31.24% | Payment of Intercompany Payables | [Income Statement Item Change Analysis](index=3&type=section&id=2%E3%80%81Major%20Income%20Statement%20Changes) Current period total operating revenue decreased by **30.83%** year-over-year due to fewer sales orders, while investment losses narrowed, but asset impairment losses expanded from increased impairment provisions for contract assets Major Income Statement Item Changes | Item | Change (%) | Primary Reason for Change | | :--- | :--- | :--- | | Total Operating Revenue | -30.83% | Decrease in Sales Orders | | Other Income | -49.15% | Decrease in Government Grants Received | | Investment Income | 69.18% | Decrease in Investment Losses from Associates | | Asset Impairment Losses | 62.23% | Increase in Impairment Losses on Contract Assets | | Income Tax Expense | 547.13% | Increase in Deferred Income Tax Expense | [Cash Flow Statement Item Change Analysis](index=3&type=section&id=3%E3%80%81Major%20Cash%20Flow%20Statement%20Changes) Net cash flow from operating activities improved by **49.62%** due to reduced procurement payments, while net cash outflow from investing activities increased by **153.64%** from higher fixed asset acquisitions, and net cash inflow from financing activities rose by **260.16%** due to increased bank borrowings Major Cash Flow Statement Item Changes | Item | Change (%) | Primary Reason for Change | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 49.62% | Decrease in Payments for Goods Purchased | | Net Cash Flow from Investing Activities | -153.64% | Increase in Acquisition of Fixed Assets | | Net Cash Flow from Financing Activities | 260.16% | Increase in Bank Loans | [Shareholder Information](index=3&type=section&id=Item%20II.%20Shareholder%20Information) [Common Stock Shareholding Information](index=3&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%20Total%20Number%20of%20Common%20Stock%20Shareholders%2C%20Preferred%20Stock%20Shareholders%20with%20Restored%20Voting%20Rights%2C%20and%20Top%20Ten%20Shareholders%27%20Holdings) As of the reporting period end, the company had **15,368** common stock shareholders, with controlling shareholder Guo Jianguo holding **31.51%** and having a concerted action relationship with Hainan Dacheng Ruixin and Guo Tiantian - At the end of the reporting period, the total number of common stock shareholders was **15,368**[12](index=12&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Shareholding Percentage (%) | Number of Shares Held | | :--- | :--- | :--- | | Guo Jianguo | 31.51% | 21,439,680.00 | | Hainan Dacheng Ruixin Investment Partnership (Limited Partnership) | 14.81% | 10,075,560.00 | | Shanghai Xuanding Asset Management Co., Ltd. - Xuanding Boyin Private Securities Investment Fund | 5.66% | 3,850,000.00 | | Guo Tiantian | 3.41% | 2,321,240.00 | - Shareholders Guo Jianguo and Guo Tiantian are father and daughter, while Guo Jianguo and Tian Shufen, a partner of Hainan Dacheng Ruixin Investment Partnership (Limited Partnership), are husband and wife, forming a concerted action relationship[13](index=13&type=chunk) [Preferred Stock Shareholding Information](index=5&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%20Total%20Number%20of%20Preferred%20Stock%20Shareholders%20and%20Top%2010%20Preferred%20Stock%20Shareholders%27%20Holdings) The company had no preferred stock shareholders during the current reporting period - During the reporting period, the company had no preferred stock shareholders[14](index=14&type=chunk) [Changes in Restricted Shares](index=5&type=section&id=%EF%BC%88%E4%B8%89%EF%BC%89%20Changes%20in%20Restricted%20Shares) During the reporting period, total restricted shares decreased from **19,117,287** to **18,985,598**, primarily due to the release of restrictions on shares held by certain former directors, supervisors, and senior management, while current executives' shares remain restricted - A total of **131,689** shares were released from restrictions in the current period, with **18,985,598** restricted shares remaining at period-end[17](index=17&type=chunk) - The release of restricted shares primarily involved former directors, supervisors, and senior management such as Xu Minhua and Zhang Guoan, whose shares were progressively unrestricted after their terms ended as per regulations[15](index=15&type=chunk)[17](index=17&type=chunk) - Restricted shares held by current directors, supervisors, and senior management (e.g., Guo Jianguo, Qu Hua) remained unchanged during this period, and their share transfers will continue to comply with relevant laws and regulations[15](index=15&type=chunk) [Other Significant Matters](index=6&type=section&id=Item%20III.%20Other%20Significant%20Matters) [Issuance of Shares to Specific Investors](index=6&type=section&id=Issuance%20of%20Shares%20to%20Specific%20Investors) The company is advancing its 2023 simplified issuance of shares to specific investors, with a revised proposal disclosed in March 2024, pending review by the Shenzhen Stock Exchange and approval from the China Securities Regulatory Commission - On March 8, 2024, the company approved the 'Proposal on the Company's 2023 Simplified Issuance of Shares to Specific Investors (Revised Draft)'[18](index=18&type=chunk) - The effectiveness and completion of this share issuance are subject to review by the Shenzhen Stock Exchange and registration approval by the China Securities Regulatory Commission[18](index=18&type=chunk) [Quarterly Financial Statements](index=6&type=section&id=Item%20IV.%20Quarterly%20Financial%20Statements) [Financial Statements](index=6&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%20Financial%20Statements) This section presents the company's unaudited Q1 2024 consolidated financial statements, including the balance sheet, income statement, and cash flow statement, comprehensively reflecting its financial position, operating results, and cash flows for the quarter [Consolidated Balance Sheet](index=6&type=section&id=1%E3%80%81Consolidated%20Balance%20Sheet) As of March 31, 2024, total assets were **CNY 681.33 million**, a **5.63%** decrease from the period-beginning, total liabilities were **CNY 156.87 million** (down **11.59%**), and owners' equity attributable to the parent company was **CNY 524.81 million** (down **3.67%**) Consolidated Balance Sheet Key Data (CNY) | Item | Period-end Balance | Period-beginning Balance | | :--- | :--- | :--- | | Total Assets | 681,325,696.81 | 721,936,739.67 | | Total Liabilities | 156,867,055.91 | 177,431,346.94 | | Total Owners' Equity Attributable to Parent Company | 524,810,370.20 | 544,831,692.35 | | Total Liabilities and Owners' Equity | 681,325,696.81 | 721,936,739.67 | [Consolidated Income Statement](index=8&type=section&id=2%E3%80%81Consolidated%20Income%20Statement) In Q1 2024, the company reported operating revenue of **CNY 13.32 million**, a **30.83%** year-over-year decrease, total operating costs of **CNY 34.93 million**, and a net loss attributable to parent company owners of **CNY 20.04 million**, widening by **27.33%** from the prior period Consolidated Income Statement Key Data (CNY) | Item | Amount for Current Period | Amount for Prior Period | | :--- | :--- | :--- | | I. Total Operating Revenue | 13,321,754.87 | 19,259,097.38 | | II. Total Operating Costs | 34,929,283.79 | 38,119,597.49 | | III. Operating Profit (Loss indicated by "-") | -19,530,673.07 | -16,085,272.13 | | IV. Total Profit (Total Loss indicated by "-") | -19,444,857.97 | -15,645,744.65 | | 1. Net Profit Attributable to Parent Company Owners | -20,036,186.01 | -15,735,302.96 | [Consolidated Cash Flow Statement](index=10&type=section&id=3%E3%80%81Consolidated%20Cash%20Flow%20Statement) In Q1 2024, net cash flow from operating activities significantly improved to **-CNY 21.12 million** from **-CNY 41.93 million** in the prior period, with net cash outflow from investing activities at **CNY 3.76 million**, net cash inflow from financing activities at **CNY 4.26 million**, and period-end cash and cash equivalents at **CNY 58.35 million** Consolidated Cash Flow Statement Key Data (CNY) | Item | Amount for Current Period | Amount for Prior Period | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -21,123,867.33 | -41,926,612.16 | | Net Cash Flow from Investing Activities | -3,756,216.73 | -1,480,930.11 | | Net Cash Flow from Financing Activities | 4,259,168.05 | 1,182,568.13 | | V. Net Increase in Cash and Cash Equivalents | -20,620,916.01 | -42,224,974.14 | | VI. Period-end Cash and Cash Equivalents Balance | 58,347,199.66 | 68,018,246.61 | [Implementation of New Accounting Standards](index=11&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%20Adjustments%20to%20Financial%20Statements%20at%20the%20Beginning%20of%20the%20First%20Year%20of%20New%20Accounting%20Standards%20Implementation%20Starting%20from%202024) The company did not adjust its period-beginning financial statements in Q1 2024 due to the initial adoption of new accounting standards - The company is not required to adjust relevant items in its 2024 period-beginning financial statements[31](index=31&type=chunk) [Audit Report](index=11&type=section&id=%EF%BC%88%E4%B8%89%EF%BC%89%20Audit%20Report) The company's Q1 2024 report is unaudited - The company's first quarter report is unaudited[31](index=31&type=chunk)

证券代码：300807 证券简称：天迈科技 公告编号：2024-033 郑州天迈科技股份有限公司 2023年度财务决算报告 郑州天迈科技股份有限公司（以下简称"公司"）2023年12月31日资产负债 表、2023年度利润表、2023年度现金流量表、2023年度所有者权益变动表及相关 报表附注经中勤万信会计师事务所（特殊普通合伙）审计，并出具标准无保留意 见的审计报告，现将公司2023年度财务决算的相关情况汇报如下： 一、2023年度主要会计数据 二、2023年度主要财务指标 | 项 目 | 2023年 | 2022年 | 同比增减 | | --- | --- | --- | --- | | 基本每股收益（元/股） | -0.74 | -0.13 | -469.23% | | 稀释每股收益（元/股） | -0.74 | -0.13 | -469.23% | | 扣除非经常性损益后的基本每股收益（元/股） | -0.81 | -0.31 | -161.29% | | 加权平均净资产收益率 | -8.78% | -1.42% | -7.36% | | 扣除非经常性损益后的加权平均净资产收益率 | -9.63% | ...

证券代码：300807 证券简称：天迈科技 公告编号：2024-007 郑州天迈科技股份有限公司 第四届监事会第五次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 二、监事会会议审议情况 （一）审议通过《关于公司 2023 年度以简易程序向特定对象发行股票竞价 结果的议案》 根据《中华人民共和国证券法》（以下简称"《证券法》"）《上市公司证 券发行注册管理办法》和《深圳证券交易所上市公司证券发行与承销业务实施细 则》等有关法律、法规和规范性文件的规定，以及公司 2022 年度股东大会的授 权，公司及主承销商于 2024 年 2 月 26 日向符合条件的投资者发送了《郑州天迈 科技股份有限公司 2023 年度以简易程序向特定对象发行股票认购邀请书》（以 下简称"《认购邀请书》"），以 2024 年 2 月 27 日作为发行期首日。经 2024 年 2 月 29 日投资者报价并根据《认购邀请书》关于确定发行对象、发行价格及获 配股数的原则，公司本次以简易程序向特定对象发行股票的最终竞价结果如下： | 序 | 发行对象 | 获配价格 | 获配股数 | 获 ...

证券代码：300807 证券简称：天迈科技 郑州天迈科技股份有限公司 2023 年度 以简易程序向特定对象发行股票预案 （修订稿） 二〇二四年三月 1 2 特别提示 本部分所述的词语或简称与本预案"释义"中所定义的词语或简称具有相同 的含义。 1、公司本次以简易程序向特定对象发行 A 股股票相关事项已由 2022 年年 度股东大会授权，已经获得公司第三届董事会第十六次会议、第四届董事会第四 次会议、第四届董事会第五次会议审议通过，且需深交所审核通过并经中国证监 会做出予以注册决定后方可实施。 发行人声明 公司及董事会全体成员保证本预案内容真实、准确、完整，并确认不存在虚 假记载、误导性陈述或重大遗漏，对预案的真实性、准确性、完整性承担个别和 连带的法律责任。 本预案按照《上市公司证券发行注册管理办法》等法规及规范性文件要求编 制。 本次以简易程序向特定对象发行股票完成后，公司经营与收益的变化，由公 司自行负责；因本次以简易程序向特定对象发行股票引致的投资风险，由投资者 自行负责。 本预案是公司董事会对本次以简易程序向特定对象发行股票的说明，任何与 之相反的声明均属不实陈述。 投资者如有任何疑问，应咨询自己的股 ...

郑州天迈科技股份有限公司 关于 2023 年度以简易程序向特定对象发行股票预案（修订稿）披露 的提示性公告 证券代码：300807 证券简称：天迈科技 公告编号：2024-010 董事会 二〇二四年三月八日 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 1 郑州天迈科技股份有限公司（以下简称"公司"）于 2024 年 3 月 8 日召 开第四届董事会第五次会议和第四届监事会第五次会议，审议并通过了《关于 公司 2023 年度以简易程序向特定对象发行股票预案（修订稿）的议案》等相关 议案。《郑州天迈科技股份有限公司 2023 年度以简易程序向特定对象发行股票 预案（修订稿）》及相关文件于 2024 年 3 月 8 日在中国证监会指定的创业板 信息披露网站巨潮资讯网（www.cninfo.com.cn）披露，敬请投资者查阅。 预案（修订稿）披露事项不代表审核、注册部门对本次发行相关事项的实 质性判断、确认或批准，预案所述本次发行股票相关事项的生效和完成尚待深 圳证券交易所审核通过，并经中国证监会同意注册。敬请广大投资者注意投资 风险。 特此公告。 郑州天迈科技股份 ...

证券代码：300807 证券简称：天迈科技 郑州天迈科技股份有限公司 2023 年度 以简易程序向特定对象发行股票方案 论证分析报告 （修订稿） 二〇二四年三月 1 郑州天迈科技股份有限公司（以下简称"公司"）是深圳证券交易所（以下 简称"深交所"）创业板上市的公司。为满足公司业务发展的需要，进一步增强 资本实力及营运能力，实现公司战略发展规划。根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"） 和《上市公司证券发行注册管理办法》（以下简称为"《注册管理办法》"）、《<上 市公司证券发行注册管理办法>第九条、第十条、第十一条、第十三条、第四十 条、第五十七条、第六十条有关规定的适用意见——证券期货法律适用意见第 18 号》（以下简称"《证券期货法律适用意见第 18 号》"）等有关法律、法规和规范 性文件的规定以及《郑州天迈科技股份有限公司章程》，公司拟以简易程序向特 定对象发行股票募集资金 69,999,982.17 元，扣除发行费用后拟用于以下项目： （本报告中如无特别说明，相关用语具有与《郑州天迈科技股份有限公司 2023 年度以简易程序向特定对象 ...